Regression of cardiac amyloidosis after stem cell transplantation assessed by cardiovascular magnetic resonance imaging

Circulation

Volumn 129, Issue 22, 2014, Pages 2326-2328

  Brahmanandam, Vikram ^a   McGraw, Sloane ^a   Mirza, Omer ^a   Desai, Ankit A ^a   Farzaneh Far, Afshin ^a,b  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GADOLINIUM;

ADULT; BONE MARROW BIOPSY; CARDIOVASCULAR MAGNETIC RESONANCE; CASE REPORT; HEART AMYLOIDOSIS; HEART FAILURE; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE VOLUME; HUMAN; MALE; MIDDLE AGED; NOTE; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION;

AMYLOIDOSIS; HEART DISEASES; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MIDDLE AGED; MYOCARDIUM; TREATMENT OUTCOME;

EID: 84901853417     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.114.009135     Document Type: Note

References (3)

1. Banypersad SM, Moon JC, Whelan C, Hawkins PM, Wechalekar AD. J Am Heart Assoc. 2012; 1:e000364.
2. Falk RH, Dubrey SW. Amyloid Heart Disease. Prog Card Dis. 2010;52:347-61.
3. Falk RH. Diagnosis and management of the cardiac amyloidoses. Circulation. 2005;112:2047-2060.